Literature DB >> 33664170

COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.

RohanKumar Ochani1, Ameema Asad1, Farah Yasmin1, Shehryar Shaikh1, Hiba Khalid1, Simran Batra1, Muhammad Rizwan Sohail2, Syed Faisal Mahmood3, Rajkumar Ochani4, Mohammad Hussham Arshad5, Arjan Kumar6, Salim Surani7.   

Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic. COVID-19 pandemic has overburdened healthcare systems in most countries and has led to massive economic losses. SARS-CoV-2 transmission typically occurs by respiratory droplets. The average incubation period is 6.4 days and presenting symptoms typically include fever, cough, dyspnea, myalgia or fatigue. While the majority of patients tend to have a mild illness, a minority of patients develop severe hypoxia requiring hospitalization and mechanical ventilation. Management is mostly supportive. However, several direct anti-viral agents, and immunomodulatory therapy with steroids and various cytokine blockers seem promising in early results. However, an effective vaccine has been established, which will help curb the pandemic.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33664170

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  16 in total

Review 1.  Myocardial injuries among patients with COVID-19: a systematic review.

Authors:  Alaa Hasan Alali; Mustafa Samir Smaisem; Ahmed Mohammed Alsheikh; Aljohara Abdullah Alshareef; Fatema Samir Smaisem; Batool Wael Alnahar; Amal Khalil Hassouneh; Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Infez Med       Date:  2021-09-10

2.  Comparison of COVID-19 characteristics in Egyptian patients according to their Toll-Like Receptor-4 (Asp299Gly) polymorphism.

Authors:  Sara I Taha; Aalaa K Shata; Eman M El-Sehsah; Manar F Mohamed; Nouran M Moustafa; Mariam K Youssef
Journal:  Infez Med       Date:  2022-03-01

Review 3.  Can food matrices be considered as a potential carrier for COVID-19?

Authors:  Amin Abbasi; Hossein Samadi Kafil; Mahdi Asghari Ozma; Narges Sangtarash; Sahar Sabahi
Journal:  Infez Med       Date:  2022-03-01

4.  Looking back on forward-looking COVID models.

Authors:  Paul Chong; Byung-Jun Yoon; Debbie Lai; Michael Carlson; Jarone Lee; Shuhan He
Journal:  Patterns (N Y)       Date:  2022-03-22

Review 5.  Experimental Models of SARS-COV-2 Infection in the Central Nervous System.

Authors:  Anna Maria Paoletti; Maria Grazia Melilli; Immacolata Vecchio
Journal:  J Cent Nerv Syst Dis       Date:  2022-06-28

6.  Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya.

Authors:  Reena Shah; Jasmit Shah; Jaimini Gohil; Gunturu Revathi; Salim Surani
Journal:  Int J Gen Med       Date:  2022-03-03

Review 7.  Saquinavir: From HIV to COVID-19 and Cancer Treatment.

Authors:  Mariana Pereira; Nuno Vale
Journal:  Biomolecules       Date:  2022-07-05

8.  Area Deprivation and COVID-19 Incidence and Mortality in Bavaria, Germany: A Bayesian Geographical Analysis.

Authors:  Kirsi Marjaana Manz; Lars Schwettmann; Ulrich Mansmann; Werner Maier
Journal:  Front Public Health       Date:  2022-07-15

Review 9.  Aspects of Antiviral Strategies Based on Different Phototherapy Approaches: Hit by the Light.

Authors:  Hannah Kunstek; Fanny Vreken; Aminata Keita; Michael R Hamblin; Florence Dumarçay; Mihayl Varbanov
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-13

Review 10.  Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19.

Authors:  Aram Yegiazaryan; Arbi Abnousian; Logan J Alexander; Ali Badaoui; Brandon Flaig; Nisar Sheren; Armin Aghazarian; Dijla Alsaigh; Arman Amin; Akaash Mundra; Anthony Nazaryan; Frederick T Guilford; Vishwanath Venketaraman
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.